109689 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
ADENOVIRAL HELPER VECTORS
#2Adenoviral Vectors Comprising Partial Deletions of E3
#3RESCUE OF RECOMBINANT ADENOVIRUSES BY CRISPR/CAS-MEDIATED IN VIVO TERMINAL RESOLUTION
#4MODIFIED ADENOVIRUSES
#5ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
#6COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#7ADENOVIRAL SEROTYPE 35 HELPER VECTORS
#8A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter
#9MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS
#10Modified adenoviruses
#11METHOD FOR PREPARING ADENOVIRUS VECTOR VACCINE BY MEANS OF PERFUSION CULTURE PROCESS
#12Adenoviral Vectors Comprising Partial Deletions of E3
#13MESENCHYMAL STEM CELLS THAT ENABLE TUMOR TARGETING IMPROVEMENT AND VIRUS MASS-PRODUCTION
#14HELPER PLASMID-BASED GUTLESS ADENOVIRUS PRODUCTION SYSTEM
#15VIRAL BIOSENSORS
#16Modified EC7 Cells Having Low Toxicity to Viral Production Payloads
#17CULTURE SYSTEMS FOR THE EFFICIENT PRODUCTION OF GENE TRANSFER VECTORS
#18ADENOVIRUS VECTORS AND USES THEREOF
#19VIRUSES WITH MODIFIED CAPSID PROTEINS
#20SINGLE PLASMID VECTOR SYSTEM FOR PACKAGING RECOMBINANT HUMAN ADENOVIRUS TYPE 4 AND APPLICATION THEREOF
#21Adenoviral vector system for gene delivery
#22Compositions and methods for viral sensitization
#23Modified adenoviruses
#24Adenoviral vectors comprising partial deletions of E3
#25Modified EC7 cells having low toxicity to viral production payloads
#26Compositions and methods for viral sensitization
#27Eukaryotic cell line
#28Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#29Life-cycle-defective adenovirus helper viruses, their production and use for producing rAAV
#30Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter
#31Adenoviral vectors comprising partial deletions of E3
#32Method for propagating adenoviral vectors encoding inhibitory gene products
#33Cell Lines
#34Compositions and methods for viral sensitization
#35Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#36Adenoviral vectors comprising partial deletions of E3
#37METHOD FOR PROPAGATING ADENOVIRAL VECTORS ENCODING INHIBITORY GENE PRODUCTS
#38Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#39Methods of propagating monkey adenoviral vectors
#40Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#41Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#42Complementing cell lines
#43Method for propagating adenoviral vectors encoding inhibitory gene products
#44Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
#45IMMORTALIZED AVIAN CELL LINES FOR VIRUS PRODUCTION
#46Methods of propagating monkey adenoviral vectors
#47Cell line from rousettus as host cell for pathogen amplification
#48Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
#49Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors
#50SYSTEM FOR PACKAGING HIGH-CAPACITY ADENOVIRUSES
#51SELF-INACTIVATING HELPER ADENOVIRUSES FOR THE PRODUCTION OF HIGH-CAPACTIY RECOMBINANT ADENOVIRUSES
#52Packaging cells for recombinant adenovirus
#53Adenoviral vectors and methods and uses related thereto
#54Vaccine against pandemic strains of influenza viruses
#55Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#56Serotype of adenovirus and uses thereof
#57Cell line for producing a non-retroviral vector
#58COMPOSITIONS AND METHODS RELATED TO AN ADENOVIRAL TRANS-COMPLEMENTING CELL LINE
#59CELLS FOR ADENOVIRUS VECTOR AND PROTEIN PRODUCTION
#60Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
#61Stocks of replication-deficient adenovirus
#62Method for propagating adenoviral vectors encoding inhibitory gene products
#63Immortalized avian cell lines for virus production
#64Complementing cell lines
#65Vaccine Against Pandemic Strains Of Influenza Viruses
#66Serotype of adenovirus and uses thereof
#67Packaging systems for human recombinant adenovirus to be used in gene therapy
#68Method for the production and purification of adenoviral vectors
#69Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof
#70Over-expression of enzymes involved in post-translational protein modifications in human cells
#71Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences
#72Adenovirus packaging cell lines
#73Serotype of adenovirus and uses thereof
#74Polynucleotides for use in recombinant adeno-associated virus virion production
#75Cell lines for production of replication-defective adenovirus
#76Packaging systems for human recombinant adenovirus to be used in gene therapy
#77Recombinant adenoviral vectors and applications thereof
#78Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
#79Packaging cells for recombinant adenovirus
#80Regulation of adenovirus DNA packaging by IPTG
#81Adenovirus packaging cell lines
#82Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
#83Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
#84Complementing cell lines
#85Packaging systems for human recombinant adenovirus to be used in gene therapy
#86Serotype of adenovirus and uses thereof
#87Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
#88Accessory functions for use in recombinant AAV virion production
#89Overexpression of enzymes involved in post-translational protein modifications in human cells
#90Serotype of adenovirus and uses thereof
#91Packaging systems for human recombinant adenovirus to be used in gene therapy
#92Adenoviral vector system
#93Diminishing viral gene expression by promoter replacement
#94Adenovirus packaging cell lines
#95Adenoviral E1A/E1B complementing cell line